Used in pharmaceutical research as a key intermediate in the synthesis of potent antiviral and antiparasitic agents. Shows particular promise in the development of drugs targeting hepatitis C and certain protozoan infections due to its ability to inhibit specific viral replication enzymes. Its structure allows for high binding affinity to target proteins, enhancing drug efficacy. Also explored in oncology for potential antitumor activity, especially in kinase inhibition pathways. Commonly employed in structure-activity relationship (SAR) studies to optimize bioavailability and metabolic stability in drug candidates.